FDA Import Refusal 799-0695960-6/31/1 — Sciegen Pharmaceuticals Inc
The FDA refused shipment 799-0695960-6/31/1 from Sciegen Pharmaceuticals Inc (United States) on Sep 6, 2022. The refused product falls under Drugs and Biologics — METFORMIN HCL (ANTI-DIABETIC). Cited charges: 118,75 This firm has 2 other import refusals on record.
Refusal Details
- Date
- Sep 6, 2022
- Country
- United States
- Product Category
- Drugs and Biologics
- Product Code
- 61PCA55 METFORMIN HCL (ANTI-DIABETIC)
- Charges
- 118,75